These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26737953)

  • 1. Wrong detection of ventricular fibrillation in an implantable cardioverter defibrillator caused by the movement near the MRI scanner bore.
    Mattei E; Censi F; Triventi M; Mancini M; Napolitano A; Genovese E; Cannata V; Falsaperla R; Calcagnini G
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7200-3. PubMed ID: 26737953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pacemaker and ICD oversensing induced by movements near the MRI scanner bore.
    Mattei E; Censi F; Calcagnini G; Falsaperla R; Genovese E; Napolitano A; Cannatà V
    Med Phys; 2016 Dec; 43(12):6621. PubMed ID: 27908173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Currents induced by fast movements inside the MRI room may cause inhibition in an implanted pacemaker.
    Mattei E; Censi F; Mancini M; Napolitano A; Genovese E; Cannatà V; Burriesci G; Falsaperla R; Calcagnini G
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():890-3. PubMed ID: 25570102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia.
    Kouakam C; Kacet S; Hazard JR; Ferraci A; Mansour H; Defaye P; Davy JM; Lambiez M;
    Europace; 2004 Jan; 6(1):32-42. PubMed ID: 14697724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.
    Cao J; Gillberg JM; Swerdlow CD
    Heart Rhythm; 2012 Apr; 9(4):522-30. PubMed ID: 22094074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
    Kazmierczak J; Tavernier R; De Sutter J; Jordaens L
    Pol Merkur Lekarski; 2000 Aug; 9(50):522-6. PubMed ID: 11081315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between pacing and arrhythmia detection algorithms in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):299-308. PubMed ID: 11500585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use.
    Gold MR; Kanal E; Schwitter J; Sommer T; Yoon H; Ellingson M; Landborg L; Bratten T
    Heart Rhythm; 2015 Mar; 12(3):631-638. PubMed ID: 25496984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachycardia detection in modern implantable cardioverter-defibrillators.
    Brüggemann T; Dahlke D; Chebbo A; Neumann I
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):171-85. PubMed ID: 27576695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of noninvasive programmed stimulation for initiating ventricular tachyarrhythmias in patients with third-generation implantable cardioverter defibrillators.
    Kleiman RB; Callans DJ; Hook BG; Marchlinski FE
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1462-8. PubMed ID: 7991416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate pauses during bradycardia pacing in a third-generation implantable cardioverter defibrillator.
    Cossú SF; Hsia HH; Simson MB; Hanna MS; Clyne CA
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2271-4. PubMed ID: 9309755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators.
    Love BA; Barrett KS; Alexander ME; Bevilacqua LM; Epstein MR; Triedman JK; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1097-101. PubMed ID: 11699514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.
    Swerdlow CD; Schsls W; Dijkman B; Jung W; Sheth NV; Olson WH; Gunderson BD
    Circulation; 2000 Feb; 101(8):878-85. PubMed ID: 10694527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
    Wilkoff BL; Hess M; Young J; Abraham WT
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1002-9. PubMed ID: 15363071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.